NLTX logo

Neoleukin Therapeutics (NLTX) CAPEX

Annual CAPEX

N/A

December 31, 2022

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

NLTX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$49.00 K
NLTX annual capital expenditures is currently at an all-time high

3-Year Low

-
NLTX annual capital expenditures 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
NLTX previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
NLTX next annual earnings announcement has not yet been scheduled

OtherNLTXcash flowmetrics:

Annual FCF

-$46.72 M
NLTX annual free cash flow is -$46.72 million

Annual CFO

-$45.61 M
NLTX annual cash flow from operations is -$45.61 million

Annual CFI

-$59.13 M
NLTX annual cash flow from investing activities is -$59.13 million

Annual CFF

$161.00 K
NLTX annual cash flow from financing activities is $161.00 thousand

Quarterly CAPEX

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NLTX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$29.00 K
NLTX quarterly capital expenditures is currently at an all-time high

3-Year Low

-
NLTX quarterly capital expenditures 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NLTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NLTX next earnings announcement has not yet been scheduled

OtherNLTXcash flowmetrics:

Quarterly FCF

-$4.27 M
NLTX quarterly free cash flow is -$4.27 million

Quarterly CFO

-$4.27 M
NLTX quarterly cash flow from operations is -$4.27 million

Quarterly CFI

-$1.61 M
NLTX quarterly cash flow from investing activities is -$1.61 million

Quarterly CFF

-$1000.00
NLTX quarterly cash flow from financing activities is -$1000.00

TTM CAPEX

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NLTX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$29.00 K
NLTX TTM capital expenditures is currently at an all-time high

3-Year Low

-
NLTX TTM capital expenditures 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NLTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NLTX next earnings announcement has not yet been scheduled

OtherNLTXcash flowmetrics:

TTM FCF

-$32.94 M
NLTX TTM free cash flow is -$32.94 million

TTM CFO

-$32.28 M
NLTX TTM cash flow from operations is -$32.28 million

TTM CFI

$17.15 M
NLTX TTM cash flow from investing activities is $17.15 million

TTM CFF

-$343.00 K
NLTX TTM cash flow from financing activities is -$343.00 thousand

NLTX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

NLTX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Neoleukin Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2018
$49.00 K
-
-
DateAnnualQuarterlyTTM
Jun 2018
-
$29.00 K
$29.00 K

FAQ

  • What is the all time high annual CAPEX for Neoleukin Therapeutics?
  • What is the all time high quarterly CAPEX for Neoleukin Therapeutics?
  • What is the all time high TTM CAPEX for Neoleukin Therapeutics?

What is the all time high annual CAPEX for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high annual capital expenditures is $49.00 K

What is the all time high quarterly CAPEX for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high quarterly capital expenditures is $29.00 K

What is the all time high TTM CAPEX for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high TTM capital expenditures is $29.00 K